Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 14986026)

1.

Astrocyte mediated MMP-9 activation in the synapse dysfunction: An implication in Alzheimer disease.

Kamat PK, Swarnkar S, Rai S, Kumar V, Tyagi N.

Ther Targets Neurol Dis. 2014;1(1). pii: e243.

2.
3.

Imaging spectrum of sporadic cerebral amyloid angiopathy: multifaceted features of a single pathological condition.

Sakurai K, Tokumaru AM, Nakatsuka T, Murayama S, Hasebe S, Imabayashi E, Kanemaru K, Takao M, Hatsuta H, Ishii K, Saito Y, Shibamoto Y, Matsukawa N, Chikui E, Terada H.

Insights Imaging. 2014 Jun;5(3):375-85. doi: 10.1007/s13244-014-0312-x. Epub 2014 Feb 12.

4.

Genetic animal models of cerebral vasculopathies.

Lee JH, Bacskai BJ, Ayata C.

Prog Mol Biol Transl Sci. 2012;105:25-55. doi: 10.1016/B978-0-12-394596-9.00002-0. Review.

5.

Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).

Zha Z, Choi SR, Ploessl K, Lieberman BP, Qu W, Hefti F, Mintun M, Skovronsky D, Kung HF.

J Med Chem. 2011 Dec 8;54(23):8085-98. doi: 10.1021/jm2009106. Epub 2011 Nov 9.

6.

Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets.

Kokjohn TA, Van Vickle GD, Maarouf CL, Kalback WM, Hunter JM, Daugs ID, Luehrs DC, Lopez J, Brune D, Sue LI, Beach TG, Castaño EM, Roher AE.

Biochim Biophys Acta. 2011 Nov;1812(11):1508-14. doi: 10.1016/j.bbadis.2011.07.004. Epub 2011 Jul 20.

7.

Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?

Humpel C.

Exp Gerontol. 2011 Apr;46(4):225-32. doi: 10.1016/j.exger.2010.11.032. Epub 2010 Nov 26. Review.

8.

Amyloid precursor protein mediates a tyrosine kinase-dependent activation response in endothelial cells.

Austin SA, Sens MA, Combs CK.

J Neurosci. 2009 Nov 18;29(46):14451-62. doi: 10.1523/JNEUROSCI.3107-09.2009.

9.

Beta-amyloid, blood vessels, and brain function.

Smith EE, Greenberg SM.

Stroke. 2009 Jul;40(7):2601-6. doi: 10.1161/STROKEAHA.108.536839. Epub 2009 May 14. Review.

10.

Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Revesz T, Holton JL, Lashley T, Plant G, Frangione B, Rostagno A, Ghiso J.

Acta Neuropathol. 2009 Jul;118(1):115-30. doi: 10.1007/s00401-009-0501-8. Epub 2009 Feb 19. Review. Erratum in: Acta Neuropathol. 2009 Aug;118(2):321.

11.

Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.

Roher AE, Esh CL, Kokjohn TA, Castaño EM, Van Vickle GD, Kalback WM, Patton RL, Luehrs DC, Daugs ID, Kuo YM, Emmerling MR, Soares H, Quinn JF, Kaye J, Connor DJ, Silverberg NB, Adler CH, Seward JD, Beach TG, Sabbagh MN.

Alzheimers Dement. 2009 Jan;5(1):18-29. doi: 10.1016/j.jalz.2008.10.004.

12.

Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice.

Austin SA, Combs CK.

Neurobiol Aging. 2010 Nov;31(11):1854-66. doi: 10.1016/j.neurobiolaging.2008.10.013. Epub 2008 Dec 5.

13.

Molecular polymorphism of Abeta in Alzheimer's disease.

Levine H 3rd, Walker LC.

Neurobiol Aging. 2010 Apr;31(4):542-8. doi: 10.1016/j.neurobiolaging.2008.05.026. Epub 2008 Jul 10.

14.

Amyloid beta toxicity dependent upon endothelial cell state.

Balcells M, Wallins JS, Edelman ER.

Neurosci Lett. 2008 Aug 29;441(3):319-22. doi: 10.1016/j.neulet.2008.06.061. Epub 2008 Jun 27.

15.

Neurogenesis and alterations of neural stem cells in mouse models of cerebral amyloidosis.

Ermini FV, Grathwohl S, Radde R, Yamaguchi M, Staufenbiel M, Palmer TD, Jucker M.

Am J Pathol. 2008 Jun;172(6):1520-8. doi: 10.2353/ajpath.2008.060520. Epub 2008 May 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk